On May 20, Consino Biotechnology published a research paper in The Lancet Respiratory Medicine, according to its official wechat account on Wednesday.Studies show that consino biological inhalation with adenovirus vector new crown vaccine kwatha (hereinafter referred to as “inhalation”) only muscle injection dosage form of 1 / 5 or 2 / 5 can produce higher than intramuscular neutralizing antibody levels, not only can stimulate humoral and cellular immunity, also can effectively induce mucosal immunity, in order to achieve triple comprehensive protection, or for efficient sequential strengthening priority.
Post time: May-27-2022